mutations and complicated kar yotype. It follows a linear evolution within the CLL clone throughout the recurrent acquisition of CDKN2ANot all sufferers with CLL call for therapy. In spite of all new improvements, the iwCLL nevertheless endorses watchful observation for sufferers with asymptomatic condition.86 This advice is based on at the very le